Buparlisib

Artikelnummer	Größe	Lieferzeit	Preis
TGM-T1827-5mg	5 mg	7 - 10 Werktage*	57,00 €
TGM-T1827-1mL	1 ml	7 - 10 Werktage*	62,00 €
TGM-T1827-10mg	10 mg	7 - 10 Werktage*	77,00 €
TGM-T1827-25mg	25 mg	7 - 10 Werktage*	94,00 €
TGM-T1827-50mg	50 mg	7 - 10 Werktage*	117,00 €
TGM-T1827-100mg	100 mg	7 - 10 Werktage*	145,00 €
TGM-T1827-200mg	200 mg	7 - 10 Werktage*	245,00 €
TGM-T1827-500mg	500 mg	7 - 10 Werktage*	445,00 €

Bei Fragen nutzen Sie gerne unser Kontaktformular.
Bestellen Sie auch per E-Mail: info@biomol.com
Größere Menge gewünscht? Bulk-Anfrage

Description: Buparlisib (BKM120) is an orally bioavailable specific oral inhibitor of the... mehr

Menü schließen

Produktinformationen "Buparlisib"

Description: Buparlisib (BKM120) is an orally bioavailable specific oral inhibitor of the pan-class I PI3K (IC50s: 52/166/116/nM for p110alpha, p110beta, and p110delta). Target: Apoptosis, PI3K. Smiles: Nc1cc(c(cn1)-c1cc(nc(n1)N1CCOCC1)N1CCOCC1)C(F)(F)F. References: Burger MT, et al. Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer. ACS Med Chem Lett. 2011 Aug 26,2(10):774-9.

Schlagworte:	BKM120, NVP-BKM120
Hersteller:	TargetMol
Hersteller-Nr:	T1827

Eigenschaften

Anwendung:	Targets phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta
MW:	410.39 D
Formel:	C18H21F3N6O2

Datenbank Information

CAS :	944396-07-0\| Passende Produkte
KEGG ID :	K00922 \| Passende Produkte
Protein Atlas Nr. :	Lipid / Phosphoinositial Signaling

Handhabung & Sicherheit

Lagerung:	-20°C
Versand:	+4°C (International: +4°C)
Signalwort:	Danger
GHS-Piktogramme:
H-Sätze:	H301, H341, H372
P-Sätze:	P201, P202, P260, P264, P270, P280, P314, P321, P330, P301+P310, P308+P313, P405, P501